Pathway paradigms revealed from the genetics of inflammatory bowel disease

[1]  Benjamin T. Porebski,et al.  Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity , 2019, Nature Immunology.

[2]  R. Locksley,et al.  Regulation of immune responses by tuft cells , 2019, Nature Reviews Immunology.

[3]  G. Coukos,et al.  Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance , 2019, Nature Reviews Clinical Oncology.

[4]  D. Plichta,et al.  Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships , 2019, Cell.

[5]  D. Philpott,et al.  NOD1 and NOD2 in inflammation, immunity and disease. , 2019, Archives of biochemistry and biophysics.

[6]  P. Auvinen,et al.  Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium , 2019, Nature.

[7]  W. Sandborn,et al.  Innovations in Oral Therapies for Inflammatory Bowel Disease , 2019, Drugs.

[8]  N. Copeland,et al.  CRISPR-Cas9–mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes , 2019, Proceedings of the National Academy of Sciences.

[9]  J. Bertin,et al.  Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. , 2019 .

[10]  Aviv Regev,et al.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.

[11]  S. Ramakrishnan,et al.  Temporal induction of intestinal epithelial hypoxia-inducible factor (HIF)-2α is sufficient to drive colitis. , 2019, American journal of physiology. Gastrointestinal and liver physiology.

[12]  F. Cominelli,et al.  Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor , 2019, Front. Pharmacol..

[13]  Eyal David,et al.  IL-23–producing IL-10Rα–deficient gut macrophages elicit an IL-22–driven proinflammatory epithelial cell response , 2019, Science Immunology.

[14]  M. Ladouceur,et al.  Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors , 2019, Current medical research and opinion.

[15]  Colin J. Brislawn,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[16]  M. Merad,et al.  IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. , 2019, The Journal of clinical investigation.

[17]  Chi A. Ma,et al.  Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire , 2019, Journal of Clinical Immunology.

[18]  Markus Rempfler,et al.  Self-organization and symmetry breaking in intestinal organoid development , 2019, Nature.

[19]  G. Núñez,et al.  A specific gene-microbe interaction drives the development of Crohn’s disease–like colitis in mice , 2019, Science Immunology.

[20]  M. Parkes,et al.  Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis , 2019, Immunity.

[21]  F. Powrie,et al.  Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. , 2019, Immunity.

[22]  R. Xavier,et al.  Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study , 2019, The Lancet.

[23]  D. Meyerholz,et al.  Loss of RHBDF2 results in an early‐onset spontaneous murine colitis , 2019, Journal of leukocyte biology.

[24]  Mark M. Davis,et al.  Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions , 2019, Nature Medicine.

[25]  S. Targan,et al.  Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models. , 2019, Cell host & microbe.

[26]  G. Kollias,et al.  Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. , 2019, Gastroenterology.

[27]  J. Kelsen,et al.  Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 , 2019, Nature.

[28]  Philip Rosenstiel,et al.  Epithelial endoplasmic reticulum stress orchestrates a protective IgA response , 2019, Science.

[29]  N. Ashley,et al.  Colonic epithelial cell diversity in health and inflammatory bowel disease , 2019, Nature.

[30]  Nupur K. Das,et al.  Intestinal non-canonical NFκB signaling shapes the local and systemic immune response , 2019, Nature Communications.

[31]  H. Clevers,et al.  Identification of Enteroendocrine Regulators by Real-Time Single-Cell Differentiation Mapping , 2019, Cell.

[32]  N. Ajami,et al.  The NLRP3 inflammasome mediates DSS-induced intestinal inflammation in Nod2 knockout mice , 2019, Innate immunity.

[33]  U. Pannicke,et al.  Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases , 2018, Proceedings of the National Academy of Sciences.

[34]  Judy H. Cho,et al.  Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy , 2019, Cell.

[35]  A. Muise,et al.  TTC7A: Steward of Intestinal Health , 2018, Cellular and molecular gastroenterology and hepatology.

[36]  A. Wuster,et al.  LACC1 Regulates TNF and IL-17 in Mouse Models of Arthritis and Inflammation , 2018, The Journal of Immunology.

[37]  B. Liu,et al.  Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons , 2018, Cell Death and Disease.

[38]  Huabing Zhang,et al.  RNF186 impairs insulin sensitivity by inducing ER stress in mouse primary hepatocytes. , 2018, Cellular signalling.

[39]  V. Wolters,et al.  SPINT2 (HAI‐2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI‐2 to inhibit prostasin but not matriptase , 2018, Human molecular genetics.

[40]  Ramnik J. Xavier,et al.  T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation , 2018, Cell.

[41]  Gudmundur A. Thorisson,et al.  A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease , 2018, Nature Communications.

[42]  T. Karlsen,et al.  Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea , 2018, Scandinavian journal of gastroenterology.

[43]  Quin F. Wills,et al.  Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease , 2018, Cell.

[44]  David A. Knowles,et al.  Landscape of stimulation-responsive chromatin across diverse human immune cells , 2018, Nature Genetics.

[45]  Patrick K. Kimes,et al.  Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease. , 2018, Gastroenterology.

[46]  T. Mcclanahan,et al.  LAG3+ Regulatory T Cells Restrain Interleukin‐23‐Producing CX3CR1+ Gut‐Resident Macrophages during Group 3 Innate Lymphoid Cell‐Driven Colitis , 2018, Immunity.

[47]  B. Stockinger,et al.  The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity , 2018, Immunity.

[48]  R. Locksley,et al.  Innate Lymphoid Cells: 10 Years On , 2018, Cell.

[49]  A. Bendelac,et al.  IgA Responses to Microbiota. , 2018, Immunity.

[50]  T. Nguyen,et al.  Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient , 2018, Nature Cell Biology.

[51]  Jennifer A. Ward,et al.  Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling , 2018, The EMBO journal.

[52]  P. Mannon,et al.  Expanded TCRβ CDR3 clonotypes distinguish Crohn’s disease and ulcerative colitis patients , 2018, Mucosal Immunology.

[53]  John G Doench,et al.  Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes. , 2018, Cell reports.

[54]  David C. Wilson,et al.  IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes , 2018, Nature Communications.

[55]  S. Nakae,et al.  Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota , 2018, Nature Immunology.

[56]  S. Brant,et al.  An increase in LRRK2 suppresses autophagy and enhances Dectin-1–induced immunity in a mouse model of colitis , 2018, Science Translational Medicine.

[57]  David T. Okou,et al.  Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease. , 2018, Gastroenterology.

[58]  Xueqiang Zhao,et al.  CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses , 2018, Nature Immunology.

[59]  F. Rieux-Laucat,et al.  Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study , 2018, Journal of Crohn's & colitis.

[60]  N. Rider,et al.  Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases , 2018, Clinical Reviews in Allergy & Immunology.

[61]  A. Wuster,et al.  Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability , 2018, ImmunoHorizons.

[62]  Mark S. Anderson,et al.  Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit , 2018, bioRxiv.

[63]  Woojung Shin,et al.  Microfluidic Organ-on-a-Chip Models of Human Intestine , 2018, Cellular and molecular gastroenterology and hepatology.

[64]  Maxim N. Artyomov,et al.  Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection , 2018, The Journal of experimental medicine.

[65]  D. Foell,et al.  Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. , 2018, Blood.

[66]  Edward T Chouchani,et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 , 2018, Nature.

[67]  M. Daly,et al.  C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions , 2018, Science.

[68]  D. Misceo,et al.  Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy , 2018, Nature Genetics.

[69]  M. van Lookeren Campagne,et al.  Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling , 2018, Nature Immunology.

[70]  Judy H. Cho,et al.  Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease , 2018, Science Translational Medicine.

[71]  F. Bastaki,et al.  Single‐center experience of N‐linked Congenital Disorders of Glycosylation with a Summary of Molecularly Characterized Cases in Arabs , 2018, Annals of human genetics.

[72]  C. Hsieh,et al.  Microbial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria , 2017, Science Immunology.

[73]  T. Kanneganti,et al.  Inflammasome activation and assembly at a glance , 2017, Journal of Cell Science.

[74]  S. V. Heesch,et al.  IL-11 is a crucial determinant of cardiovascular fibrosis , 2017, Nature.

[75]  Yarden Katz,et al.  A single-cell survey of the small intestinal epithelium , 2017, Nature.

[76]  Joshua A. Bittker,et al.  Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease , 2017, Proceedings of the National Academy of Sciences.

[77]  C. Taylor,et al.  Regulation of immunity and inflammation by hypoxia in immunological niches , 2017, Nature Reviews Immunology.

[78]  A. Kaser,et al.  Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation , 2017, The Journal of experimental medicine.

[79]  Howard Y. Chang,et al.  Discovery of stimulation-responsive immune enhancers with CRISPR activation , 2017, Nature.

[80]  Hailiang Huang,et al.  Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[81]  C. Abraham,et al.  Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes , 2017, Nature Communications.

[82]  G. Dubyak,et al.  Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease , 2017, The Journal of Biological Chemistry.

[83]  R. Owens,et al.  Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease , 2017, Nature Medicine.

[84]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[85]  Tariq Ahmad,et al.  Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease , 2017, Nature Genetics.

[86]  C. Klein,et al.  Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. , 2016, Gastroenterology.

[87]  Steven A Carr,et al.  TMEM258 Is a Component of the Oligosaccharyltransferase Complex Controlling ER Stress and Intestinal Inflammation. , 2016, Cell reports.

[88]  Adam R. Johnson,et al.  Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity , 2016, Science Translational Medicine.

[89]  Judy H. Cho,et al.  Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population , 2016, bioRxiv.

[90]  A. Bradley,et al.  C13orf31 (FAMIN) is a central regulator of immunometabolic function , 2016, Nature Immunology.

[91]  K. Takeda,et al.  Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186 , 2016, Mucosal Immunology.

[92]  M. Daly,et al.  Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk. , 2016, Immunity.

[93]  David C. Wilson,et al.  Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.

[94]  Eric E Schadt,et al.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease. , 2016, Gastroenterology.

[95]  Smita Y. Patel,et al.  Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease , 2016, Gut.

[96]  Søren Brunak,et al.  Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci , 2016, Nature Genetics.

[97]  Beryl B. Cummings,et al.  A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis , 2015, Nature Communications.

[98]  Y. Wada,et al.  SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation. , 2015, American journal of human genetics.

[99]  Rona S. Gertner,et al.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity , 2015, Cell.

[100]  M. Daly,et al.  Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation. , 2015, Immunity.

[101]  Erin Stevens,et al.  Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation. , 2015, Immunity.

[102]  Hans Clevers,et al.  Single-cell messenger RNA sequencing reveals rare intestinal cell types , 2015, Nature.

[103]  Christine E. Becker,et al.  Functional genomics identifies negative regulatory nodes controlling phagocyte oxidative burst , 2015, Nature Communications.

[104]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[105]  Chun Jimmie Ye,et al.  A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks , 2015, Cell.

[106]  Paul A. Lyons,et al.  T cell exhaustion, costimulation and clinical outcome in autoimmunity and infection , 2015, Nature.

[107]  R. Locksley,et al.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. , 2015, Immunity.

[108]  S. Latour,et al.  XIAP deficiency syndrome in humans. , 2015, Seminars in cell & developmental biology.

[109]  E. Campbell,et al.  Stabilization of HIF through inhibition of Cullin‐2 neddylation is protective in mucosal inflammatory responses , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[110]  Hailiang Huang,et al.  High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis , 2014, Nature Genetics.

[111]  Kari Stefansson,et al.  Rare mutations associating with serum creatinine and chronic kidney disease. , 2014, Human molecular genetics.

[112]  Yasmine Belkaid,et al.  The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine , 2014, Nature.

[113]  Lin Li,et al.  Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome , 2014, Nature.

[114]  C. Klein,et al.  Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.

[115]  G. Friedlander,et al.  Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. , 2014, Immunity.

[116]  Jacob D. Jaffe,et al.  Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense , 2014, Proceedings of the National Academy of Sciences.

[117]  J. DeVoss,et al.  A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3 , 2014, Nature.

[118]  R. Xavier,et al.  IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans , 2014, Proceedings of the National Academy of Sciences.

[119]  R. Nemenoff,et al.  Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.

[120]  E. Campbell,et al.  Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis , 2013, Proceedings of the National Academy of Sciences.

[121]  J. Greenson,et al.  Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. , 2013, Gastroenterology.

[122]  A. Kaser,et al.  Paneth cells as a site of origin for intestinal inflammation , 2013, Nature.

[123]  Judy H. Cho,et al.  Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis , 2013, PLoS genetics.

[124]  E. Kuipers,et al.  Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease , 2013, Gut.

[125]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[126]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[127]  Y. Rojanasakul,et al.  An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. , 2012, Immunity.

[128]  Joshua M. Korn,et al.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease , 2011, Nature Genetics.

[129]  N. Warner,et al.  Cutting Edge: Crohn’s Disease-Associated Nod2 Mutation Limits Production of Proinflammatory Cytokines To Protect the Host from Enterococcus faecalis-Induced Lethality , 2011, The Journal of Immunology.

[130]  K. Murthy,et al.  Endogenous IGFBP‐3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures , 2011, Inflammatory bowel diseases.

[131]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[132]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[133]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[134]  Sarah L. Brown,et al.  A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.

[135]  H. Tilg,et al.  XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease , 2008, Cell.

[136]  Judy H Cho,et al.  Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease , 2008, Nature Genetics.

[137]  V. Nizet,et al.  A Nod2–nalp1 Complex Mediates Caspase-1-dependent Il-1␤ Secretion in Response to Bacillus Anthracis Infection and Muramyl Dipeptide Nod2, a Nod-like Receptor (nlr), Is an Intracellular Sensor of Bacterial Muramyl Dipeptide (mdp) That Was Suggested to Promote Secretion of the Proinflammatory Cytokine , 2022 .

[138]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[139]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[140]  J. Penninger,et al.  The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors , 2007, Nature Immunology.

[141]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[142]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[143]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[144]  F. Martinon,et al.  Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome , 2004, Current Biology.

[145]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[146]  J. Bertin,et al.  Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[ d]thiazol-5-ylamino)-6-( tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. , 2019, Journal of medicinal chemistry.

[147]  S. Ng,et al.  Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. , 2017, Gastroenterology.

[148]  R. Xavier,et al.  Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. , 2014, Gastroenterology.

[149]  Naoki Ishiguro,et al.  A MULTICENTRE STUDY , 2010 .

[150]  B. Becher,et al.  RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. , 2009, Gastroenterology.

[151]  Margaret Comerford Freda,et al.  10 Years. , 2008, MCN. The American journal of maternal child nursing.

[152]  F. Jamali,et al.  Single dose pharmacokinetics and bioavailability of glucosamine in the rat. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.